This market analysis examined Mohs surgeons' dominance in the skin cancer surgery market, evaluating trends in procedure volume, market share, and practice patterns. The data confirmed that Mohs surgeons perform the majority of skin cancer surgeries and that this market share continues to grow.

Mohs surgeons continue to expand their market share in skin cancer surgery due to superior cure rates and tissue conservation.

The growing dominance of Mohs surgery reflects broader trends toward evidence-based, cost-effective skin cancer treatment.